Related Experiment Videos

Decreased CCAAT/enhancer binding protein β expression inhibits the growth of glioblastoma cells

D Aguilar-Morante1, M Cortes-Canteli, M Sanz-Sancristobal

  • 1Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Arturo Duperier, 4 and Centro de Investigación Biomédica en Red sobre Enfermedades neurodegenerativas (CIBERNED), 28029-Madrid, Spain.

Neuroscience
|December 28, 2010
PubMed

Insights

CCAAT enhancer-binding protein beta (C/EBPβ) is crucial for glioma cell proliferation and migration. Depleting C/EBPβ inhibits glioblastoma growth, delays tumor onset, and improves survival in mice.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • CCAAT enhancer-binding protein beta (C/EBPβ) is a transcription factor involved in various cellular processes.
  • Its specific role in tumor development, particularly in glioblastoma, remains largely undefined.

Purpose of the Study:

  • To investigate the role of C/EBPβ in glioblastoma cell proliferation, migration, and tumor development.
  • To explore C/EBPβ's regulation of genes associated with DNA damage response and invasion.

Main Methods:

  • RNA interference (RNAi) was used to down-regulate C/EBPβ in the GL261 murine glioblastoma cell line.
  • Cell cycle analysis, transformation assays, and migration assays were performed.
  • Gene expression related to DNA damage and invasion was analyzed.
  • An orthotopic brain tumor model in mice was utilized to assess tumor onset and survival.

Main Results:

  • Down-regulation of C/EBPβ inhibited GL261 cell proliferation and induced G0/G1 cell cycle arrest.
  • C/EBPβ depletion reduced glioblastoma cell transformation capacity and migration.
  • C/EBPβ regulates key genes involved in DNA damage response and invasion.
  • C/EBPβ depletion significantly delayed tumor onset and prolonged survival in a murine brain tumor model.
  • Reduced proliferating cell nuclear antigen (PCNA) labeling was observed in tumors with depleted C/EBPβ.

Conclusions:

  • Glioma cells are dependent on C/EBPβ for proliferation and survival.
  • C/EBPβ plays a significant role in glioma development and progression.
  • C/EBPβ represents a potential therapeutic target for glioblastoma.